Showing 2651-2660 of 5771 results for "".
- Tickets and Sponsorships Available for 2026 Prevent Blindness Person of Vision Award Gala Honoring Jim McGrannhttps://modernod.com/news/tickets-and-sponsorships-available-for-2026-prevent-blindness-person-of-vision-award-gala-honoring-jim-mcgrann/2485427/Prevent Blindness has announced that tickets and sponsorship opportunities remain available for the 2026 Prevent Blindness Person of Vision Award gala, which will honor Jim McGrann, CEO of Advancing Eyecare, for his decades of leadership and dedication to improving
- New Collaboration to Produce Opticianry-Focused Educational Panel at OptiCon ’26https://modernod.com/news/new-collaboration-to-produce-opticianry-focused-educational-panel-at-opticon-26/2485385/The Contact Lens Institute (CLI) and the United Opticians Association (UOA) announced a new collaboration to co-produce "Vision for Growth: Consumer Perspectives on Opticianry & Contact Lens Success," an educational panel exclusive to OptiCon ’26 @ Vision Expo.
- Focus Vitamins Launches Preservative-Free Artificial Tears to Address Rising Eye Drynesshttps://modernod.com/news/focus-vitamins-launches-preservative-free-artificial-tears-to-address-rising-eye-dryness/2485384/Focus Vitamins announced the launch of Focus Tears PF Eye Drops, a new preservative-free artificial tear designed to provide fast, soothing relief for dry, irritated eyes. The new product is formulated to address common symptom
- Newton and ABB Labs Enter Partnership to Expand Access to Lens Portfolio in UShttps://modernod.com/news/newton-and-abb-labs-enter-partnership-to-expand-access-to-lens-portfolio-in-us/2485363/Newton announced that it has selected ABB Labs, an independent optical laboratory network, as a strategic laboratory partner. The collaboration aims to expand access to Newton’s lens portfolio across the United States. Accordi
- Nanodropper Now Operating as Mu Medical Under New Consolidation Planhttps://modernod.com/news/nanodropper-now-operating-as-mu-medical-under-new-consolidation-plan/2485284/Nanodropper, provider of micro-volume ophthalmic delivery technology, announced that Bedo Solutions and Viseon Labs have agreed on terms to join its eyecare platform under a new corporate identity, Mu Medical. Financial terms of the deal were not disclosed.
- CooperVision to Launch of MyDay MiSight 1 Day Contact Lenses in Europehttps://modernod.com/news/coopervision-to-launch-of-myday-misight-1-day-contact-lenses-in-europe/2485287/CooperVision announced the upcoming launch of MyDay MiSight 1 day contact lenses in the UK and select European and surrounding markets. The new daily disposable soft contact lens combines MiSight 1 day ActivControl Technology,
- Exploring a Connection Between GLP-1 Drugs and Vision Losshttps://modernod.com/news/exploring-a-connection-between-glp-1-drugs-and-vision-loss/2484306/Two studies presented at the 2025 AAO Annual Meeting explored a possible connection between GLP-1 drugs and vision loss. Using data from the World Health Organization’s global database of drug safety reports, researchers at the University of Ottawa Eye Institute, University of Tor
- Duke Eye Center Implants Cell-Based Therapy for MacTelhttps://modernod.com/news/duke-eye-center-implants-cell-based-therapy-for-mactel/2484304/Duke Eye Center announced that its team is the first at a US academic medical center to implant a new commercially available cell-based gene therapy for macular telangiectasia type 2 (MacTel). No treatment was available to slow the progression of MacTel until the FDA approved revakinagene taroret
- Everest Medicines Expands into Ophthalmology with Licensing Agreement for Retinal Disease Candidate in Asiahttps://modernod.com/news/everest-medicines-expands-into-ophthalmology-with-licensing-agreement-for-retinal-disease-candidate-in-asia/2484302/Everest Medicines announced it has entered into an exclusive licensing agreement with Visara, a subsidiary of NovaBridge Biosciences to develop, manufacture, and commercialize VIS-101 in Greater China, Singapore, South Korea, and select Southeast Asian countri
- Celularity Enters Strategic Partnership with DefEYE to Advance Regenerative Therapies in Eye Carehttps://modernod.com/news/celularity-enters-strategic-partnership-with-defeye-to-advance-regenerative-therapies-in-eye-care/2484300/Celularity announced a strategic partnership with DefEYE, a newly established ophthalmic product and technology company. Under the terms of the agreement, Celularity has executed an exclusive license and pricing arrangement with DefEYE, following Celularity&rs